Valkyrie Pharma continues its good run on AnabolicLab with the analysis of its injectable testosterone enanthate product.
Valkyrie Pharma was selected for the fifth time for steroid analytics by AnabolicLab. The lucky product to undergo testing this time was Testosterone E250.
Valkyrie Pharmaceutical Testosterone E250 claims to contain 250 milligrams of testosterone enanthate in every milliliter of injectable solution. AnabolicLab has partnered with SIMEC AG in Switzerland to analyze and verify such claims.
New lab report: Valkyrie Pharmaceutical Testosterone E250 Lab Test Results https://t.co/IDrrZgDtBn #harmreduction #steroids
— Anabolic Lab (@AnabolicLab) September 22, 2016
Valkyrie Pharma Testosterone E250 contains what it says it does.
Valkyrie Pharma Testosterone E250 actually contained 281.8 mg/ml of testosterone enanthate according to the HPLC-UV analysis performed by SIMEC.
This was well within the 20% acceptable deviation from the label claim established by AnabolicLab. And close to RoidVisor’s preferred 10% limit as well.
When it comes to underground steroid products, consumers are generally thrilled to see products so accurately dosed.
With five products tested (and hopefully counting), Valkyrie Pharma’s track record on AnabolicLab has been very good. Trenbolone E200, Oxyject 50, Deca 300, Winny 50 and Testosterone E250 have all passed.
